Design and Development of Small-Molecule Arylaldoxime/5-Nitroimidazole Hybrids as Potent Inhibitors of MARK4: A Promising Approach for Target-Based Cancer Therapy-Reference-Cited by-同舟云学术

Design and Development of Small-Molecule Arylaldoxime/5-Nitroimidazole Hybrids as Potent Inhibitors of MARK4: A Promising Approach for Target-Based Cancer Therapy

Published:2020-09-01 Issue:36 Volume:5 Page:22759-22771
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Peerzada Mudasir Nabi¹,Khan Parvez²,Khan Nashrah Sharif²³,Avecilla Fernando⁴,Siddiqui Shadab Miyan¹,Hassan Md. Imtaiyaz²^ORCID,Azam Amir¹^ORCID

Affiliation:

1. Medicinal Chemistry Research Laboratory, Department of Chemistry, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India

2. Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India

3. Department of Biotechnology, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India

4. Grupo Xenomar, Centro de Investigacións Científicas Avanzadas (CICA), Departamento de Química, Facultade de Ciencias, Universidade da Coruña, Campus A Coruña, 15071 A Coruña, Spain

Funder

Indian Council of Medical Research

Council of Scientific and Industrial Research

Science and Engineering Research Board

Department of Biotechnology , Ministry of Science and Technology

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.acs.org/doi/pdf/10.1021/acsomega.0c01703

Reference65 articles.